Found: 13
Select item for more details and to access through your institution.
Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 144, doi. 10.1177/1479164119826479
- By:
- Publication type:
- Article
Insulin resistance: Impact on therapeutic developments in diabetes.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 128, doi. 10.1177/1479164119827570
- By:
- Publication type:
- Article
Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 178, doi. 10.1177/1479164119827598
- By:
- Publication type:
- Article
Personal Memories.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 207, doi. 10.1177/1479164119829999
- Publication type:
- Article
The Reaven syndrome: An historical perspective.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 116, doi. 10.1177/1479164119828899
- By:
- Publication type:
- Article
Gerald Reaven: A man for our times.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 118, doi. 10.1177/1479164119827611
- By:
- Publication type:
- Article
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 171, doi. 10.1177/1479164119827604
- By:
- Publication type:
- Article
Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 196, doi. 10.1177/1479164118825343
- By:
- Publication type:
- Article
Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 133, doi. 10.1177/1479164118825376
- By:
- Publication type:
- Article
Effects of obesity on insulin: insulin-like growth factor 1 hybrid receptor expression and Akt phosphorylation in conduit and resistance arteries.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 160, doi. 10.1177/1479164118802550
- By:
- Publication type:
- Article
Impact of race/ethnicity on insulin resistance and hypertriglyceridaemia.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 153, doi. 10.1177/1479164118813890
- By:
- Publication type:
- Article
Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 186, doi. 10.1177/1479164118810691
- By:
- Publication type:
- Article